Products

Blue Genes AI-Powered Pharmacogenetics
Blue Genes
Clinical Decision Support & Reference
Blue Genes is a leading pharmacogenetics (PGx) solution that leverages AI to provide real-time suggestions of clinically appropriate alternative therapies based on pharmacogenomic data, supporting safer prescribing and reducing administrative load for providers.

See all 1 product →

About Blue Genes

Blue Genes is a healthcare AI company focused on transforming medication decisions through real-time pharmacogenetics. Their AI-powered platform aims to proactively prevent harmful prescriptions and adverse drug reactions by providing immediate, data-driven recommendations to healthcare providers. The company’s mission is to eliminate genetically driven adverse drug reactions, protect patients, reduce preventable costs for health plans, and bring precision to every prescription decision.

The platform integrates complex genetic insights into clear, actionable guidance at the point of care, helping providers understand how a patient’s unique DNA impacts their response to medications. Blue Genes offers an app-based tool that considers both drug-drug and gene-drug interactions to suggest optimal medications. They also leverage Google’s Gemini AI and Google Cloud to streamline communication with patients and providers through intelligent voice and chat agents, offering HIPAA-aware support and real-time suggestions for alternative therapies when prescriptions are denied.

Blue Genes’ solutions are designed for system compatibility, integrating with Pharmacy Benefit Managers (PBMs), Electronic Medical Records (EMRs), and pharmacy systems. This integration allows for real-time claim denials if a prescribed medication is not efficacious for a patient based on their genetics, without requiring behavioral changes from patients or adding significant administrative burden to providers. They also offer a personalized, at-home genetic testing kit.

Focus Areas

pharmacogenetics precision medicine AI in healthcare adverse drug reaction prevention medication management genetic testing real-time clinical support

Business Intelligence

TechnologyAI-powered platform, Google's Gemini AI, Google Cloud, patent-pending technology, API for PBM and EMR integration, cloud-native

What Physicians Need to Know

Pharmacogenomics (PGx) Integration
Blue Genes specializes in integrating pharmacogenomic insights directly into healthcare workflows, enabling real-time, personalized prescribing decisions. Their platform helps providers understand how a patient's unique DNA impacts their response to medications, aiming to reduce adverse drug reactions by 50% and avoid unnecessary or ineffective prescriptions.
AI-Powered Clinical Support
The company leverages AI, including Google's Gemini AI, to provide rapid and informed answers to both providers and patients. This includes real-time recommendations for alternative medications based on FDA data, case studies, and peer-reviewed literature.
Real-Time Intervention at Point of Care
Blue Genes' patent-pending technology delivers secure, scalable access to PGx insights at the point of care, ensuring lightning-fast response times (sub-second latency) for smooth integration with existing systems and minimal disruption to clinical workflows.
Automated Communication Tools
They offer AI-powered intelligent voice and chat agents built on Google Cloud to streamline and personalize communication with patients and providers. These tools handle tasks like reminding patients about genetic test kits, explaining claim denials, and suggesting alternative therapies to doctors.
Comprehensive Genetic Analysis
Blue Genes provides an app-based tool that considers both drug-drug and gene-drug interactions to suggest the best medications for a patient. They also offer at-home testing kits for genetic incompatibility and drug-to-drug interactions.
GLP-1 Related Gene Analysis
Blue Genes has expanded its clinical testing panel to include genes that influence GLP-1 biology, aiming to improve personalized treatment strategies for metabolic conditions like type 2 diabetes and obesity.
Physician Tip

For physicians, Blue Genes offers a powerful tool to move beyond trial-and-error prescribing by providing real-time, personalized medication guidance based on a patient's genetic profile. The platform integrates seamlessly into existing EMRs and PBMs, delivering actionable insights at the point of care without requiring significant changes to clinical workflows. AI-powered clinical support and communication tools reduce administrative burden, offer immediate suggestions for alternative therapies, and help ensure compliance, allowing physicians to focus on delivering exceptional patient care. The goal is to empower providers to prescribe with confidence, reduce adverse drug reactions, and improve patient outcomes by aligning medications with individual genetic profiles.

Blue Genes' platform is designed for seamless integration with leading Pharmacy Benefit Managers (PBMs) and Electronic Medical Records (EMRs). They utilize an open-source API that can be integrated into adjudication engines for real-time claim processing and medication guidance. The company has active partnerships with various PBMs and healthcare technology companies like Levrx and RxSense to embed precision medicine into existing benefit infrastructures.

Products by Blue Genes

1 product in the directory

Blue Genes AI-Powered Pharmacogenetics
Blue Genes
Clinical Decision Support & Reference
Blue Genes is a leading pharmacogenetics (PGx) solution that leverages AI to provide real-time suggestions of clinically appropriate alternative therapies based on pharmacogenomic data, supporting safer prescribing and reducing administrative load for providers.

Videos

News, demos, and interviews about Blue Genes.

Loading videos...

Videos load interactively. If none appear, search YouTube for Blue Genes →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Blue Genes offers an AI-powered pharmacogenomics (PGx) platform that provides real-time drug interaction and prescription drug delivery insights. Their AI tools, powered by Google's Gemini AI, include intelligent voice and chat agents for patient and provider communication, offering 24/7 support, explaining claim denials, and suggesting alternative therapies based on pharmacogenomic data.
Blue Genes states that all genetic and health-related data is stored and transmitted in compliance with HIPAA security rules. They also indicate that they do not use genetic data for marketing or share it with third parties without explicit consent, and they employ industry-standard safeguards like encryption and secure access controls.
While specific pricing details for Blue Genes' core pharmacogenomics platform are not publicly available, they mention that for their GLP-1 genetic testing, a one-time test can offset thousands in wasted therapy spend. Another company named BlueGenAI, which focuses on government AI solutions, is finalizing flexible pricing options for integrators, government agencies, and enterprise-scale modernization efforts.
Blue Genes provides customer support via email and phone, and they have a dedicated support center to assist with questions, concerns, or issues. They also offer consultations with experienced PharmD team members to help users understand their pharmacogenomic reports.
Blue Genes has established several strategic partnerships, including with RxSense to integrate PGx insights into pharmacy benefit workflows, with Levrx Technology to integrate genetic insights into the pharmacy benefit experience, and with Level Care to provide pharmacogenomic testing to union members. They also leverage Google's Gemini AI and Google Cloud for their AI communication tools.
Blue Genes was founded in 2022 and is currently an unfunded company. It operates as a privately held company with no external backing and has 574 active competitors.
Blue Genes' patent-pending technology is designed for seamless integration with existing systems, including EMRs and PBMs. Their API delivers real-time pharmacogenomic insights at the point of care and is built for system compatibility to minimize disruption to clinical workflows.

Related Companies

Medicomp Systems is a healthcare technology company that specializes in transforming complex, fragmented healthcare data into structured, clinically relevant information. Founded in 1978, the company’s core offering is the Quippe platform, powered by its patented MEDCIN® Knowledge Engine and Clinical Knowledge Graph™. This technology is designed to reflect how clinicians think and work, providing diagnostically […]

Loop Studio, operating getaskmed.com, develops AI tools specifically for healthcare providers and physicians. Their product, AskMed, is designed to assist medical professionals, though it is explicitly stated not to be a symptom checker. The company focuses on creating applications that can be accessed across various platforms, including iPhone, iPad, Android, and the web. Loop Studio […]

Foundation29 is a non-profit organization dedicated to leveraging artificial intelligence to improve the diagnosis of rare and complex diseases. Inspired by the personal experience of its founder, Julián Isla, whose son faced a prolonged diagnostic journey for Dravet syndrome, the organization aims to shorten the time to diagnosis from years to days. Their primary product, […]

Mayo Clinic Platform is a strategic initiative of Mayo Clinic that aims to transform healthcare globally by leveraging data and technology. It focuses on redefining how care is provided, making personalized, predictive, and innovative care accessible to all. The platform supports innovation and collaboration around secure, de-identified clinical data to create, validate, and scale digital […]

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.